| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10908756 | Leukemia Research | 2014 | 8 Pages |
Abstract
In conclusion, dasatinib/fludarabine combination has modest clinical efficacy in fludarabine-refractory patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Arnon P. Kater, Marjolein Spiering, Roberto D. Liu, G. Doreen te Raa, E. Slinger, Sanne H. Tonino, Marielle M. Beckers, Simon Daenen, Jeanette K. Doorduijn, Nienke A.G. Lankheet, Dieuwertje M. Luijks, Eric Eldering, Marinus H.J. van Oers,